Evidence map›Paper›PMID 40736789›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

In Vitro Maturation and Time-Lapse Imaging of Immature Human Oocytes: A Direction Toward Clinical Applications.

Xavier Pollet-Villard, Mohamed Yahiatene, Alpesh Doshi

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xavier Pollet-VillardNataliance ART and Andrology Center, MLAB Group, Pôle Santé Oréliance, Saran, France.
Mohamed YahiateneNataliance ART and Andrology Center, MLAB Group, Pôle Santé Oréliance, Saran, France.
Alpesh DoshiIVF London, Elstree, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, multiple teams reported the successful utilization of denuded oocytes matured in vitro after controlled ovarian stimulation, as well as their small but significant contribution to cumulative live-birth rates after intracytoplasmic sperm injection (ICSI). Published data are in favor of rescue ICSI when mature oocytes are obtained one day after oocyte pickup, the clinical contribution being higher for patient with advanced maternal age, low ovarian response to COS, low maturation rate, or low fertilization rate. From a strictly resource-oriented perspective, rescue ICSI of immature oocytes may not be cost-effective as it would require additional expenses related to consumables, media, and embryologist time and as the developmental potential of such oocytes is consistently decreased across reported studies compared to their sibling mature oocytes. Being able to select the right clinical context as well as the right oocytes to fertilize to optimize outcome and resources spent is thus of significant clinical value. In that regard, even if more costly than conventional culture, time-lapse imaging may play an important role as morphokinetic markers of oocyte maturation and oocyte developmental potential have been described. However, the limited number of reported cases warrants for the restricted use of rescue ICSI only in registered clinical trials with long-term follow-up of children obtained from this still experimental procedure.

Indexed as

In Vitro Oocyte Maturation TechniquesOocytesTime-Lapse ImagingFemaleHumansSperm Injections, IntracytoplasmicControlled ovarian stimulationGerminal vesicle oocytesICSIIn vitro maturationIVFMetaphase 1 oocytesMetaphase 2 oocytesRescue-ICSITime-lapse imaging

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.